- Home
- VCEL vs EAD Comparison
VCEL vs EAD Comparison
Compare VCEL & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- EAD
- Stock Information
- Founded
- VCEL 1989
- EAD 2003
- Country
- VCEL United States
- EAD United States
- Employees
- VCEL N/A
- EAD N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- EAD Finance/Investors Services
- Sector
- VCEL Health Care
- EAD Finance
- Exchange
- VCEL Nasdaq
- EAD Nasdaq
- Market Cap
- VCEL 2.1B
- EAD 406.6M
- IPO Year
- VCEL 1997
- EAD N/A
- Fundamental
- Price
- VCEL $40.25
- EAD $7.04
- Analyst Decision
- VCEL Strong Buy
- EAD
- Analyst Count
- VCEL 8
- EAD 0
- Target Price
- VCEL $62.00
- EAD N/A
- AVG Volume (30 Days)
- VCEL 477.0K
- EAD 178.9K
- Earning Date
- VCEL 07-31-2025
- EAD 01-01-0001
- Dividend Yield
- VCEL N/A
- EAD 8.91%
- EPS Growth
- VCEL 521.85
- EAD N/A
- EPS
- VCEL 0.05
- EAD N/A
- Revenue
- VCEL $238,541,000.00
- EAD N/A
- Revenue This Year
- VCEL $23.03
- EAD N/A
- Revenue Next Year
- VCEL $24.52
- EAD N/A
- P/E Ratio
- VCEL $780.58
- EAD N/A
- Revenue Growth
- VCEL 14.80
- EAD N/A
- 52 Week Low
- VCEL $37.39
- EAD $5.69
- 52 Week High
- VCEL $63.00
- EAD $6.81
- Technical
- Relative Strength Index (RSI)
- VCEL 44.06
- EAD 68.99
- Support Level
- VCEL $39.39
- EAD $7.00
- Resistance Level
- VCEL $42.61
- EAD $7.14
- Average True Range (ATR)
- VCEL 1.73
- EAD 0.06
- MACD
- VCEL -0.15
- EAD 0.01
- Stochastic Oscillator
- VCEL 24.16
- EAD 77.14
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.